Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DENMUSIN: Denosumab on Muscle Strength and Insulin Sensitivity
NCT07271771Phase 4Recruiting
- Sponsor
- Aarhus University Hospital
- Start
- May 2024
- Primary completion
- Mar 2027
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of denosumab in type 2 diabetes mellitus (T2DM), osteoporosis, sponsored by Aarhus University Hospital. Started May 2024; status: recruiting.
02
Drugs
denosumab
03
Conditions
type 2 diabetes mellitus (T2DM)osteoporosis
Beyond the preview
Go deeper on NCT07271771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07271771.